Cancer Family
Genitourinary System Neoplasm
CI-CAN-00000018Explore in graph →
Non-malignant3,849 active trials61 approved drugs306 evidence items
- NCIt
- C156482
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000018Explore in graph →
Clinical trials
17,388 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01244438 | Study of FP-1039 in Subjects With Endometrial Cancers | withdrawn | Phase 2 | 0 | Five Prime Therapeutics, Inc.INDUSTRY | 0 | Dec 13, 2021 | clinicaltrials |
| NCT03400306 | A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian Cancer | withdrawn | Phase 1 | 0 | AbbVieINDUSTRY | 0 | Dec 8, 2021 | clinicaltrials |
| Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer |
| withdrawn |
| Phase 1 / Phase 2 |
| 0 |
| Immune System Key LtdINDUSTRY |
| 1 |
| Oct 26, 2021 |
| clinicaltrials |
| NCT03495479 | Aneustat Treatment of Localized Prostate Cancer Under Active Surveillance(CAMPAS) | withdrawn | — | 0 | Omnitura Therapeutics, Inc.INDUSTRY | 0 | Oct 18, 2021 | clinicaltrials |
| NCT04280640 | Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes | withdrawn | — | 0 | UNC Lineberger Comprehensive Cancer CenterOTHER | 0 | Oct 18, 2021 | clinicaltrials |
| NCT03607955 | Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Sep 29, 2021 | clinicaltrials |
| NCT00161252 | Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly | withdrawn | — | 0 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Sep 27, 2021 | clinicaltrials |
| NCT04020094 | Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer(AtezoVax) | withdrawn | Phase 2 | 0 | University of UtahOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT04403568 | Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate | withdrawn | Early Phase 1 | 0 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Sep 16, 2021 | clinicaltrials |
| NCT04680416 | Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors | withdrawn | — | 0 | TScan Therapeutics, Inc.INDUSTRY | 1 | Aug 25, 2021 | clinicaltrials |
| NCT04296578 | Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone | withdrawn | Phase 1 | 0 | Stanford UniversityOTHER | 0 | Aug 12, 2021 | clinicaltrials |
| NCT03933761 | Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy(PRECISE) | withdrawn | Phase 2 | 0 | Australia New Zealand Gynaecological Oncology GroupOTHER | 0 | Aug 10, 2021 | clinicaltrials |
| NCT02127151 | A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer(PANDA) | withdrawn | Phase 2 | 0 | University College, LondonOTHER | 1 | Aug 6, 2021 | clinicaltrials |
| NCT02108613 | Living Well on Androgen Deprivation Therapy | withdrawn | N/A | 0 | British Columbia Cancer AgencyOTHER | 1 | Jul 29, 2021 | clinicaltrials |
| NCT03806049 | Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer | withdrawn | Phase 3 | 0 | Nordic Society of Gynaecological Oncology - Clinical Trials UnitOTHER | 3 | Jul 15, 2021 | clinicaltrials |
| NCT04486846 | Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth) | withdrawn | N/A | 0 | Duke UniversityOTHER | 1 | Jun 10, 2021 | clinicaltrials |
| NCT04498520 | Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer | withdrawn | Phase 1 | 0 | Pamela MunsterOTHER | 0 | May 18, 2021 | clinicaltrials |
| NCT04464967 | Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers | withdrawn | Phase 1 / Phase 2 | 0 | NKGen Biotech, Inc.INDUSTRY | 0 | May 12, 2021 | clinicaltrials |
| NCT01802307 | Focal Therapy for Prostate Cancer | withdrawn | Phase 2 | 0 | University of Maryland, BaltimoreOTHER | 1 | May 11, 2021 | clinicaltrials |
| NCT01566045 | MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer | withdrawn | N/A | 0 | Philips HealthcareINDUSTRY | 1 | Apr 28, 2021 | clinicaltrials |
| NCT01401777 | Electromagnetic Tracking of Devices During Interventional Procedures - A Cryoablation Study | withdrawn | — | 0 | Philips HealthcareINDUSTRY | 1 | Apr 27, 2021 | clinicaltrials |
| NCT00621413 | Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer | withdrawn | — | 0 | IsoRay Medical, Inc.INDUSTRY | 1 | Apr 19, 2021 | clinicaltrials |
| NCT02497638 | LIpitor and biGuanide to Androgen Delay Trial(LIGAND) | withdrawn | Phase 2 | 0 | University Health Network, TorontoOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT03902379 | Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer | withdrawn | N/A | 0 | Rutgers, The State University of New JerseyOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT03189186 | Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas | withdrawn | Phase 1 | 0 | University of California, IrvineOTHER | 1 | Apr 5, 2021 | clinicaltrials |
| NCT03589781 | Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the Prostate | withdrawn | N/A | 0 | Nikkei (Canada) Marketing LimitedINDUSTRY | 1 | Mar 30, 2021 | clinicaltrials |
| NCT02295163 | Stellate Ganglion Block for Hot Flushes in Men Treated With ADT | withdrawn | N/A | 0 | Rijnstate HospitalOTHER | 1 | Mar 10, 2021 | clinicaltrials |
| NCT04585932 | Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT03042897 | Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer | withdrawn | N/A | 0 | University of Southern CaliforniaOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT04027270 | Pelvic Health and Physical Therapy to Improve Lives of Prostate Cancer Patients Undergoing Prostatectomy | withdrawn | N/A | 0 | University of Missouri-ColumbiaOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT03563352 | Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer | withdrawn | — | 0 | University of Southern CaliforniaOTHER | 1 | Dec 14, 2020 | clinicaltrials |
| NCT03308734 | Effects of 6 Week Reduced Exertion High Intensity Interval Training Protocol in Patients With Prostate Cancer | withdrawn | N/A | 0 | University of BathOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT01097239 | Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Imperial College LondonOTHER | 1 | Nov 20, 2020 | clinicaltrials |
| NCT01691976 | Mild Cognitive Impairment in Men Following Androgen Deprivation | withdrawn | N/A | 0 | Imperial College LondonOTHER | 1 | Nov 20, 2020 | clinicaltrials |
| NCT03173859 | Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC Patients(AERA) | withdrawn | Phase 2 | 0 | University of AthensOTHER | 0 | Nov 18, 2020 | clinicaltrials |
| NCT04262375 | A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION(DOMINATION) | withdrawn | Phase 2 | 0 | University Health Network, TorontoOTHER | 1 | Nov 17, 2020 | clinicaltrials |
| NCT04225299 | Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer | withdrawn | Phase 3 | 0 | Steba Biotech S.A.OTHER | 1 | Nov 13, 2020 | clinicaltrials |
| NCT01925378 | A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia | withdrawn | Phase 2 | 0 | The University of Texas Health Science Center, HoustonOTHER | 1 | Nov 12, 2020 | clinicaltrials |
| NCT04399824 | Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer | withdrawn | N/A | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 6, 2020 | clinicaltrials |
| NCT04197219 | Pembrolizumab With Axitinib in Recurrent Endometrial Cancer | withdrawn | Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Nov 5, 2020 | clinicaltrials |
| NCT04567095 | A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Patients in Canada | withdrawn | — | 0 | AllerganINDUSTRY | 1 | Oct 23, 2020 | clinicaltrials |
| NCT03110588 | Phase I Trial of PACE for Metastatic Prostate Cancer | withdrawn | Phase 1 | 0 | University of Alabama at BirminghamOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT03540199 | Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer | withdrawn | Phase 2 | 0 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT02822963 | Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate | withdrawn | — | 0 | National Cheng-Kung University HospitalOTHER | 1 | Oct 6, 2020 | clinicaltrials |
| NCT04561817 | To Evaluate the Safety and Efficacy of Ipatasertib (GDC-0068) in Combination With Paclitaxel in Platinum-resistant Recurrent Epithelial Ovarian Cancer | withdrawn | Phase 2 | 0 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Oct 6, 2020 | clinicaltrials |
| NCT01079793 | Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery | withdrawn | Phase 1 / Phase 2 | 0 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 20, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Dec 13, 2021source: clinicaltrials